Latest Articles
Pete Davidson's Girlfriend Elsie Hewitt: 5 Things to Know - Us Weekly
Pete Davidson's Girlfriend Elsie Hewitt: 5 Things to Know Us Weekly
Published: Dec. 22, 2025, 11:27 a.m.
Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer - Nature
Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer Nature
Published: Dec. 22, 2025, 10:55 a.m.
Hisense 55-inch Class QLED 4K CanvasTV Series for just $697.99 - Mashable
Hisense 55-inch Class QLED 4K CanvasTV Series for just $697.99 Mashable
Published: Dec. 22, 2025, 10 a.m.
Get $1,400 off a 100-inch Hisense TV at Best Buy - Mashable
Get $1,400 off a 100-inch Hisense TV at Best Buy Mashable
Published: Dec. 22, 2025, 10 a.m.
Rare surgery brings relief to endometriosis patient at Ottawa hospital - CBC
Rare surgery brings relief to endometriosis patient at Ottawa hospital CBC
Published: Dec. 22, 2025, 9 a.m.
Pregnancy After Endometriosis: Debunking Myths And Facts - ABP Live English
Pregnancy After Endometriosis: Debunking Myths And Facts ABP Live English
Published: Dec. 22, 2025, 8:54 a.m.
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com - Investing.com South Africa
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com Investing.com South Africa
Published: Dec. 22, 2025, 8:15 a.m.
Gesynta Pharma forms Scientific Advisory Board with international endometriosis experts - beQuoted
Gesynta Pharma forms Scientific Advisory Board with international endometriosis experts beQuoted
Published: Dec. 22, 2025, 8:15 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - The AI Journal
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer The AI Journal
Published: Dec. 22, 2025, 7:31 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - itemonline.com
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer itemonline.com
Published: Dec. 22, 2025, 7:30 a.m.
Link copied to clipboard!